Featured Videos
Latest Videos
Video
How Bacteria Cause Disease
Join Warren Levinson to learn about the various agents that cause infectious diseases: bacteria, viruses, fungi, protozoa and worms, with a focus on how bacteria are transmitted and cause disease, and how exotoxins and endotoxins cause symptoms of disease.
Video
The Price of Immunity
Dr. Rick Hecht discusses the flip side of the immune system, highlighting how it can actually damage our body if its pushed too hard, or if it experiences one of many possible malfunctions.
Video
Engineering Immune Cells to Recognize and Kill Cancer
Find out how scientists are using immune proteins to mobilize immune cells to fight cancer with Michael Fischbach and Kole Roybal.
Video
Biologic Agents: Treatment of Autoimmune Diseases
Dr. Andrew Gross, UCSF Rheumatology Clinic Director, explores the latest strategies in the treatment of autoimmune diseases.
Video
Beautiful 3-D Reconstructions of Brain Cells and All Their Synapses
Prof Jeff Lichtman describes his group's work to map the brain from the synapses up.
Video
Basic Immunology: Nuts and Bolts of the Immune System
Dr. Anthony DeFranco explores basic immunology, looking at the cells in the immune system, what they do and how they work.
Video
Resolve Your Western Blotting Woes with Better Antibodies
PrecisionAb™ Validated Western Blotting Antibodies are our solution to the current pain points of many protein scientists looking for high-quality, trustworthy antibodies to detect their protein of interest with minimal optimization.
Video
How Does an Antibody Become a PrecisionAb™ Antibody?
For a primary antibody to be selected as a PrecisionAb Antibody, it must be highly specific, highly sensitive, and pass a rigorous validation process that includes consistent performance from batch to batch.
Video
Early Stage Drug Discovery: Assay Development and Compound Profiling
LabTube Meets Dr Jon Hutchinson, Scientific Leader, GlaxoSmithKline (GSK), UK at ELRIG Drug Discovery 2017.
Jon shares his professional background and discusses his role in early stage drug discovery at GSK. He provides his thoughts on the evolution of drug discovery over the duration of his career, emphasizing the shift in industry focus.
Jon shares his professional background and discusses his role in early stage drug discovery at GSK. He provides his thoughts on the evolution of drug discovery over the duration of his career, emphasizing the shift in industry focus.
Video
Incentives for Innovation: Drug Development and Intellectual Property
There are over 7000 new medicines in development: without Intellectual Property this simply would not be possible.
Advertisement